等待开盘 09-18 09:30:00 美东时间
-1.020
-1.49%
Henry Schein (NASDAQ:HSIC) has authorized the repurchase of up to $750 million of shares of the company's common stock. This program is in addition to the $500 million repurchase program announced in ...
09-10 05:28
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced today that its Board of Directors has authorized the
09-10 05:13
Henry Schein ( ($HSIC) ) has issued an announcement. James Breslawski, who tran...
09-10 04:33
Full-Service Laboratory Management Firm Helps Elevate Clinical Lab Operations NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., h...
09-09 22:18
Analysts' ratings for Henry Schein (NASDAQ:HSIC) over the last quarter vary fro...
08-26 20:01
Evercore ISI Group analyst Elizabeth Anderson upgrades Henry Schein (NASDAQ:HSIC) from In-Line to Outperform and announces $83 price target.
08-26 19:21
(来源:医趋势) 8月7日,美国医疗器械企业HistoSonics宣布,一个由私募和公募投资者组成的联盟已完成对其多数股权的收购,此次收购由公司管理层主导。...
08-11 12:05
今日重点评级关注:HC Wainwright & Co.:维持FibroGen"买入"评级,目标价从10美元升至43美元;摩根大通:维持Cogent Biosciences"超配"评级,目标价从29美元升至30美元
08-08 09:34
6 analysts have expressed a variety of opinions on Henry Schein (NASDAQ:HSIC) o...
08-07 05:03